Thyroid Cancer Management, Iodine Nutrition, and Autoimmune Thyroid Disease
This research community investigates the diagnosis and treatment of thyroid cancer, the physiological impact of iodine intake on human health, and the management of autoimmune thyroid disorders.
The work centers on differentiated thyroid carcinoma, specifically papillary thyroid cancer, and the application of radioactive iodine therapy for its treatment. A substantial portion of the literature addresses iodine deficiency, iodine status, and iodine intake, with significant focus on pregnant women and children. Recurring themes include the management of thyroid nodules, the use of sodium iodide, and the pathophysiology of Graves' disease. The community also examines the molecular mechanisms of thyroid dysfunction, including the role of the iodide symporter and thyroid hormone regulation. Clinical practice guidelines for thyroid nodule management and Graves' orbitopathy are frequently cited, alongside studies on the nutritional implications of iodized salt and iodine concentration in various populations.
The largest share of the community's output is found in iodine research, accounting for 16.4% of all iodine research, and 12,057 papers here.
There are 19,140 papers in this community, primarily published in The Journal of Clinical Endocrinology & Metabolism, Thyroid, and Endocrinology.
Recent work includes studies on the prognostic significance of BRAF V600E and TERT promoter mutations in radioiodine resistance, the role of interleukin 17 in autoimmune thyroid diseases, and the impact of sustainable diets on micronutrient intakes.